NCT05186740 - ProVee Urethral Expander System IDE Study (ProVIDE) | Biotech Hunter

Enrollment

221

Participants

Timeline

Start Date

June 9, 2022

Primary Completion Date

March 15, 2024

Study Completion Date

December 31, 2028

Conditions

Benign Prostatic Hyperplasia With Symptomatic Lower Urinary Tract Symptoms

Interventions

DEVICE

ProVee Urethral Expander System

ProVee Expander is placed in prostatic urethra to relieve obstruction due to BPH.

PROCEDURE

Urethral Access Sheath

The Urethral Access Sheath is introduced into the prostatic urethra to simulate the placement of the ProVee Expander.

Trial Locations (17)

10011

Mount Sinai, New York

10016

Manhattan Medical Research Practice, New York

23462

Urology of Virginia, Virginia Beach

27612

Associated Urologists of North Carolina, Raleigh

32164

Advanced Urology Institute, Palm Coast

33016

Urological Research Network Corp, Hialeah

33606

Tampa Urology LLC, Tampa

34787

Avant Concierge Urology, Winter Garden

60010

Comprehensive Urologic Care, Lake Barrington

62702

Southern Illinois University School of Medicine, Springfield

77030

Houston Methodist, Houston

78705

Midtown Urology Assoc., Austin

78745

Urology Austin, Austin

89144

Sheldon Freedman MD, Las Vegas

95823

Golden State Urology, Sacramento

M5T 2S8

University Health Network, Toronto

Unknown

St James's Hospital, Dublin